期刊名称：ANNALS OF SAUDI MEDICINE
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
The Annals of Saudi Medicine is published bimonthly by King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia. We publish scientific reports of clinical interest in English. All submissions are subject to peer review by the editorial board and by reviewers in appropriate specialties. The journal will consider for publication manuscripts from any part of the world, but particularly reports that would be of interest to readers in the Middle East or other parts of Asia and Africa. Please go to the Author Resource Center for additional information.
THOMSON REUTERS IMPACT FACTOR
Instructions to Authors
Author Resource Center
For information for authors and an author checklist for manuscript preparation, log in to your ScholarOne account (http://mc.manuscriptcentral.com/asm), click on "Instructions & Forms" in the upper right and download the PDFs.
Please note that on matters of scientific misconduct (duplicate publication, fragmented data, undisclosed conflict of interest, plagiarism and others) we follow the guidelines of the Committee on Publication Ethics (www.publicationethics.org). Authors who violate these guidelines may be placed on our watchlist and subject to a ban on future submission.
Links for Authors and Reviewers
EQUATOR
EQUATOR <http://www.equator-network.org> (Enhancing the QUAlity of Trials and Other Research). The EQUATOR Network seeks to improve the quality of scientific publications by promoting transparent and accurate reporting of health research. The EQUATOR site has links to the following guidelines as well as others.
STROBE
STROBE (STrengthening the Reporting of OBservational studies in Epidemiology) is an international, collaborative initiative of epidemiologists, methodologists, statisticians, researchers and editors involved in the conduct and dissemination of observational studies.
The TREND statement was specifically developed to guide standardized reporting of nonrandomized controlled trials. The TREND statement complements the widely adopted CONsolidated Standards Of Reporting Trials (CONSORT) statement developed for randomized controlled trials. A collective effort in promoting transparent reporting is valuable to improve research synthesis and advance evidence-based recommendations for best practices and policies. We encourage all researchers, funding agencies, journal editors, and reviewers to use the TREND Statement as a guide when designing evaluation studies, reporting evaluation results, and reviewing manuscripts for scientific publication.
STARD
The STARD (Standards for Reporting of Diagnostic Accuracy) initiative aims to improve the accuracy and completeness of reporting of studies of diagnostic accuracy in order to allow readers to assess the potential for bias in a study and to evaluate the generalisability of its results.
Nomenclature for human genes:
Please use the guidelines developed by the Human Gene Organization (HUGO) nomenclature committee for human genes:
Human genes
Use approved gene symbols obtained from the HUGO Nomenclature Committee (http://www.genenames.org/). Another useful reference is the AMA Manual of Style, Section 15.6.2 Human Gene Nomenclature (http://www.amamanualofstyle.com)
Human genetic variation
Designation of single nucleotide polymorphisms (SNPs), deletions, insertions and other gene mutations should follow the guidelines given in Hum Genet 2001; 109:121–124 (http://www.springerlink.com/content/20y8jygwcyewmf5a/).
Human cytogenics
Use ISCN nomenclature for cytogenetics notation: Schaffer LG, Slovak ML, Campbell LJ. ISCN 2009: An International System for Human Cytogenetic Nomenclature (2009): Recommendations of the International Standing Committee on Human Cytogenetic Nomenclature. S. Karger AG (Switzerland);2009.
Mouse strain and genetic nomenclature: International Committee on Standardised Genetic Nomenclature for Mice (http://www.informatics.jax.org/) new symbols and names for genes should be obtained before submission.
Human gene names and loci should be written in uppercase italics and Arabic numerals. Protein products are not italicized.
Adapted from Guidance for Authors on the Preparation and Submission of Manuscripts to Pharmacogenetics and Genomics
Editorial Board
Editor-in-Chief
Mohammed Ahmed,MD
Endocrinology, KFSHRC
Associate Editors-in-Chief
Naeem Chaudhri, MD
Oncology, KFSHRC
Irfan Magfoor, MD
Oncology, KFSHRC
Abdullah Al Khenizan, MD
Family Medicine and Polyclinics, KFSHRC
Khalid Awartani, MD
Obstetrics and Gynecology, KFSHRC
Editorial Board Members
M. Zuheir Al-Kawi, MD
Neurosciences, KFSHRC
Abdulrahman Alrajhi, MD
Infectious Diseases, KFSHRC
Sami Al-Hajjar, MD
Pediatric Infectious Diseases, KFSHRC
Suliman Al Jumaah, MD
Pediatric Infectious Diseases, KFSHRC
Nasser Al-Sanea, MD
Colorectal Surgery, KFSHRC
Hadeel Al Mana, MD
Pathology and Laboratory Medicine, KFSHRC
Hindi Al Hindi, MD
Pathology and Laboratory Medicine, KFSHRC
Moussa Gary Sayed, PhD
Biomedical Physics Department, KFSHRC
Mohammed Al-Omran, MD
Postgraduate and Continuing Medical Education,
King Saud University
Saeed Bohlega, MD
Neurosciences, KFSHRC
Mohamed Shoukri, MD
Biostatistics, Epidemiology and Scientific Computing, KFSHRC
Salah Baz, MD
Neurosciences, KFSHRC
Nabil Al Zaher, MD
Otolaryngology/Head & Neck Surgery/Communication Sciences, KFSHRC
Ayman Al-Jazaeri, MD
Pediatric Surgery, King Saud University
Nawal Salahuddin, MD
Adult Critical Care Medicine, KFSHRC
Mohamed Ahmed, MPharm
Pharmacy Services Division, KFSHRC
Mohammed Khalid, MD
Pulmonary Medicine, KFSHRC
Ahmed Waqas, MD
Heart Center, KFSHRC
Bandar Al Ghamdi, MD
Heart Center, KFSHRC
Taimur Butt, MD
Emergency Medicine, KFSHRC
INTERNATIONAL CONSULTING EDITORS
Peter Hall, MD, PhD
Editor-in-Chief,
Journal of Pathology
Queen’s University, Belfast,
United Kingdom
Mehmood Khan, MD
CEO, Global Nutrition Group
SVP, Chief Scientific Officer
PepsiCo Chicago, Illinois, USA
PAST EDITORS
Ali S. Alzahrani
Mahmoud Aljurf
Mohammed Akhtar
Peter Herdson
John Fox
Kamal Hanash
Nizar Feteih
Contact Us
Editorial Office
Annals of Saudi Medicine
Scientific Publications Office (MC36)
Academic & training Affairs
King Faisal Specialist Hospital and Research Centre
PO Box 3354, Riyadh 11211
Saudi Arabia
T: 966-1-464-7272 ext. 31819
F: 966-1-464-7272 ext. 31875
Email: admin@annsaudimed.net
|
